Once-daily controlled release remoxipride is equieffective with twice-daily immediate release remoxipride in the treatment of schizophrenia. Journal of Psychopharmacology, January 1993, 7. vsk, nro 3, s. 276–82. PubMed:22290842doi:10.1177/026988119300700307
Remoxipride therapy in treatment resistant schizophrenia. Schizophrenia Research, April 1993, 9. vsk, nro 2-3, s. 235–236. doi:10.1016/0920-9964(93)90521-J
Remoxipride therapy in poorly responsive schizophrenics. Schizophrenia Research, April 1993, 4. vsk, nro 3. doi:10.1016/0920-9964(91)90208-9
nih.gov
pubmed.ncbi.nlm.nih.gov
Once-daily controlled release remoxipride is equieffective with twice-daily immediate release remoxipride in the treatment of schizophrenia. Journal of Psychopharmacology, January 1993, 7. vsk, nro 3, s. 276–82. PubMed:22290842doi:10.1177/026988119300700307